Developmental expression of α4 protein phosphatase regulatory subunit in tissues affected by Opitz syndrome
Open Access
- 27 June 2002
- journal article
- research article
- Published by Wiley in Developmental Dynamics
- Vol. 224 (4) , 461-464
- https://doi.org/10.1002/dvdy.10125
Abstract
Mutations in the Mid1 gene are responsible for X‐linked Opitz syndrome, characterized by midline defects of the brain, face, heart, and trachea. The regulatory subunit α4 binds protein phosphatase 2A to Mid1 and promotes Mid1 dephosphorylation, in opposition to MAP kinase. To examine the relationship between α4 expression and human defects in Opitz syndrome, developmental expression of α4 in embryonic day (E) 8–E16 mouse embryos was mapped by immunohistochemistry. At E10, α4 was first detected only in the heart. At E11, α4 was expressed in epithelium of the mandibular and maxillary arches and in specific subsets of mesenchymal cells within the arches. The fetal heart and brain also highly expressed α4. At E16, α4 expression broadened to include the heart, brain, skeletal muscle, and tracheal and esophageal epithelium but not smooth muscle. Consistent with immunolocalization in embryos, Western immunoblotting of adult rabbit tissues demonstrated high levels of α4 expression in brain, heart, lung, liver, and skeletal muscle with low expression in kidney, uterus, and intestine. Expression in slow type I skeletal muscle was much higher than in fast type II muscle. By using double immunohistochemical staining, α4 was coexpressed in mouse skeletal muscle cells containing slow type myosin. Expression of α4 overlaps with the tissue defects in Opitz syndrome. The α4 gene lies in the linkage interval for FG syndrome, characterized by skeletal muscle and brain defects that coincide closely to the expression pattern of α4.Keywords
This publication has 13 references indexed in Scilit:
- MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, Alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disordersBMC Cell Biology, 2002
- MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradationNature Genetics, 2001
- Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4Proceedings of the National Academy of Sciences, 2001
- New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndromeHuman Molecular Genetics, 2000
- The Opitz syndrome gene product, MID1, associates with microtubulesProceedings of the National Academy of Sciences, 1999
- Expression and Chromosomal Localization of the Human α4/IGBP1 Gene, the Structure of Which Is Closely Related to the Yeast TAP42 Protein of the Rapamycin-Sensitive Signal Transduction PathwayGenomics, 1997
- A gene for FG syndrome maps in the Xq12-q21.31 regionAmerican Journal of Medical Genetics, 1997
- Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22Nature Genetics, 1997
- Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases.Genes & Development, 1996
- Studies of malformation syndromes of man XXXIII: The FG syndrome. An X-linked recessive syndrome of multiple congenital anomalies and mental retardationEuropean Journal of Pediatrics, 1974